Skip to main content
User account menu
Log in
X
Main navigation
About
Leadership
Advisory Board
News & Announcements
Messages from Our Leaders and Colleagues
Press Releases
HIV in the News
Events & Training
Grants & Funding
People
Email Groups
Publications
Requests for Manuscripts
Resources
Search
Home
News & Announcements
HIV / AIDS in the News
HIV progam rule challenge back in administrative court; attorneys conference in circuit court case - Florida Phoenix
Thursday, February 26 2026 - 16:44
$300K for HIV-positive seniors not included in SF budget ask - Bay Area Reporter
Thursday, February 26 2026 - 16:38
Nurse at Texas Jail Is Fired After Possibly Exposing Inmates to HIV - poz.com
Thursday, February 26 2026 - 16:23
Advocates warn cuts to HIV/AIDS drug assistance are a ‘death warrant’ for Floridians - WMNF 88.5 FM
Thursday, February 26 2026 - 15:57
Bictegravir-Lenacapavir: Further Study Insights on the Investigative HIV Therapy - Contagion Live
Thursday, February 26 2026 - 15:28
Aging With HIV: Notes From the Long Haul - poz.com
Thursday, February 26 2026 - 15:28
[CROI 2026] MedPage Today: Age, HIV, and metabolic syndrome together tied to cognitive impairment risk - European AIDS Treatment Group
Thursday, February 26 2026 - 15:14
'Paradigm-shifting' study confirms effectiveness of long-acting HIV treatment - University of Cincinnati
Thursday, February 26 2026 - 15:01
President Trump: Save Florida’s AIDS Drug Assistance Program! - AIDS Healthcare Foundation
Thursday, February 26 2026 - 14:55
New HIV drug may end multi-pill regimen for older people - DW.com
Thursday, February 26 2026 - 14:52
CROI 2026: Meaningful Progress, Expanding Choice - avac.org
Thursday, February 26 2026 - 14:28
Positive 12-month data shows lotivibart maintains high levels of viral suppression in long-acting HIV treatment regimen - The Pharma Letter
Thursday, February 26 2026 - 14:28
Florida Department of Health cuts millions of dollars in funds from HIV and AIDS drug program - CBS News
Thursday, February 26 2026 - 14:27
Very Early ART Initiation in Children With HIV Could Lead to ART-Free Remission - MedPage Today
Thursday, February 26 2026 - 14:26
Injectable ART Suppressed HIV Long-Term in Teens - MedPage Today
Thursday, February 26 2026 - 14:26
Southern Nevada's Black community continues to face higher-than-average HIV rates - KNPR
Thursday, February 26 2026 - 13:48
[CROI 2026] Life4me+: Doravirine/islatravir for initial HIV therapy: A two-drug strategy in a three-drug world - European AIDS Treatment Group
Thursday, February 26 2026 - 13:19
GSK's ViiV confirms staying power of long-acting HIV treatment Cabenuva in adolescents - Fierce Pharma
Thursday, February 26 2026 - 13:00
Valley Healthcare to offer two opportunities for free HIV testing in March - WRBL
Thursday, February 26 2026 - 12:55
[CROI 2026] aidsmap: Bictegravir/lenacapavir combination pill could be an option for people taking complex regimens - European AIDS Treatment Group
Thursday, February 26 2026 - 12:49
Why is Florida ending longtime HIV drug assistance to more than 10,000? - Naples Daily News
Thursday, February 26 2026 - 12:46
Why is Florida ending longtime HIV drug assistance to more than 10,000? - The Palm Beach Post
Thursday, February 26 2026 - 12:46
Bictegravir/lenacapavir combination pill could be an option for people taking complex regimens - Aidsmap
Thursday, February 26 2026 - 12:20
[CROI 2026] [Press release] ViiV Healthcare reports positive 12-month data showing investigational bNAb lotivibart (N6LS) maintains high levels of viral suppression in long-acting HIV treatment regimen - European AIDS Treatment Group
Thursday, February 26 2026 - 12:04
[CROI 2026] [Press release] ViiV Healthcare presents pipeline data for two investigational HIV treatment therapies with potential for twice-yearly dosing - European AIDS Treatment Group
Thursday, February 26 2026 - 11:53
PrEP uptake was already low – and then came the cuts - Aidsmap
Thursday, February 26 2026 - 11:50
New data adds to case for bictegravir and lenacapavir in HIV - The Pharma Letter
Thursday, February 26 2026 - 11:48
[CROI 2026] [Press release] Merck announces late-breaking data from three Phase 3 trials evaluating doravirine/islatravir, an investigational, once-daily, two-drug regimen for the treatment of adults living with HIV-1 - European AIDS Treatment Group
Thursday, February 26 2026 - 11:24
Thousands of Floridians could lose HIV medication - Jacksonville Today
Thursday, February 26 2026 - 11:18
From Ending the HIV Epidemic to Uncertain Ground: PrEP4All's Peter Staley - AJMC
Thursday, February 26 2026 - 11:13
Pagination
First page
« First
Previous page
‹‹
…
Page
105
Page
106
Page
107
Page
108
Current page
109
Page
110
Page
111
Page
112
Page
113
…
Next page
››
Last page
Last »